Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides
- 31 December 1995
- Vol. 13 (14) , 1288-1293
- https://doi.org/10.1016/0264-410x(95)00052-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Polysaccharide-Protein Conjugates: A New Generation of VaccinesThe Journal of Infectious Diseases, 1990
- Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.The Journal of Experimental Medicine, 1987
- AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINEThe Lancet, 1985
- Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within GroupsThe Journal of Infectious Diseases, 1983
- Pneumococcal vaccination of recipients of bone marrow transplantsArchives of internal medicine (1960), 1983
- Some Observations on the Pneumococcus and on the Current Status of Pneumococcal Disease and Its PreventionClinical Infectious Diseases, 1981
- Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.The Journal of Experimental Medicine, 1980
- Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the futureImmunochemistry, 1978
- IMPAIRMENT OF THE IMMUNE RESPONSE TO VACCINATION AFTER ACUTE MALARIAThe Lancet, 1978
- CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINSThe Journal of Experimental Medicine, 1929